In a relief to US pharma major Merck Sharp and Dohme, the Supreme Court on Friday restrained Indian firm Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met.
SC restrains Glenmark from making Merck’s drug
No comments:
Post a Comment